HUP0102699A2 - Solution of n-[o-(p-pivaloyloxybenzene-sulfonylamino)-benzoyl]-glycine monosodium salt tetrahydrate and pharmaceutical composition containing it - Google Patents

Solution of n-[o-(p-pivaloyloxybenzene-sulfonylamino)-benzoyl]-glycine monosodium salt tetrahydrate and pharmaceutical composition containing it

Info

Publication number
HUP0102699A2
HUP0102699A2 HU0102699A HUP0102699A HUP0102699A2 HU P0102699 A2 HUP0102699 A2 HU P0102699A2 HU 0102699 A HU0102699 A HU 0102699A HU P0102699 A HUP0102699 A HU P0102699A HU P0102699 A2 HUP0102699 A2 HU P0102699A2
Authority
HU
Hungary
Prior art keywords
pivaloyloxybenzene
sulfonylamino
benzoyl
solution
pharmaceutical composition
Prior art date
Application number
HU0102699A
Other languages
English (en)
Inventor
Masao Sudoh
Akira Takada
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of HU0102699D0 publication Critical patent/HU0102699D0/hu
Publication of HUP0102699A2 publication Critical patent/HUP0102699A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HU0102699A 2000-06-29 2001-06-28 Solution of n-[o-(p-pivaloyloxybenzene-sulfonylamino)-benzoyl]-glycine monosodium salt tetrahydrate and pharmaceutical composition containing it HUP0102699A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000195853 2000-06-29
JP2000195852 2000-06-29

Publications (2)

Publication Number Publication Date
HU0102699D0 HU0102699D0 (en) 2001-08-28
HUP0102699A2 true HUP0102699A2 (en) 2002-06-29

Family

ID=26594951

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102699A HUP0102699A2 (en) 2000-06-29 2001-06-28 Solution of n-[o-(p-pivaloyloxybenzene-sulfonylamino)-benzoyl]-glycine monosodium salt tetrahydrate and pharmaceutical composition containing it

Country Status (19)

Country Link
US (1) US6552082B2 (hu)
EP (1) EP1166773B1 (hu)
KR (1) KR100725076B1 (hu)
CN (1) CN1263736C (hu)
AT (1) ATE259218T1 (hu)
AU (1) AU782838B2 (hu)
BR (1) BR0102604B1 (hu)
CA (1) CA2351273C (hu)
DE (1) DE60101979T2 (hu)
DK (1) DK1166773T3 (hu)
ES (1) ES2215856T3 (hu)
HU (1) HUP0102699A2 (hu)
MX (1) MXPA01006698A (hu)
NO (1) NO330296B1 (hu)
NZ (1) NZ512486A (hu)
PT (1) PT1166773E (hu)
RU (1) RU2272623C2 (hu)
TR (1) TR200400585T4 (hu)
TW (1) TWI246925B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2416600A1 (en) * 2000-07-24 2003-01-20 Ono Pharmaceutical Co., Ltd. Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof
US20050101633A1 (en) * 2001-05-17 2005-05-12 Takeharu Tonai Remedial agent for myelopathic disease
TW200519080A (en) * 2003-10-03 2005-06-16 Ono Pharmaceutical Co Agent containinf (2R)-2-propyloctanic acid as effective component
CA2707484C (en) 2007-12-04 2021-08-10 Remedy Pharmaceuticals, Inc. Improved formulations and methods for lyophilization and lyophilates provided thereby
KR101247137B1 (ko) * 2011-03-23 2013-04-01 주식회사 엠씨켐 Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법
KR101366706B1 (ko) 2012-12-06 2014-02-24 상명대학교서울산학협력단 Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법
CN104107172B (zh) * 2013-04-18 2017-11-28 上海汇伦生命科技有限公司 西维来司钠注射用冻干粉的制备方法
CN114681435A (zh) * 2020-12-31 2022-07-01 上海汇伦生物科技有限公司 吸入用药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320253A (ja) 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
CA1340191C (en) 1988-06-13 1998-12-15 Katsuhiro Imaki Derivatives of p-substituted phenyl ester of pivalic acid
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.
JP3020253B2 (ja) 1990-05-02 2000-03-15 松下電工株式会社 配線器具の取付枠への取付構造
EP0539223A1 (en) 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
JPH05194366A (ja) 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
JP3193597B2 (ja) 1995-07-28 2001-07-30 小野薬品工業株式会社 グリシン誘導体の製造方法
AU5528299A (en) 1998-09-15 2000-04-03 Naeja Pharmaceutical Inc. Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
AU6870800A (en) * 1999-09-06 2001-04-10 Ono Pharmaceutical Co. Ltd. Preventive and therapeutic agents for eye diseases

Also Published As

Publication number Publication date
KR100725076B1 (ko) 2007-06-08
RU2272623C2 (ru) 2006-03-27
NO20013223D0 (no) 2001-06-27
ES2215856T3 (es) 2004-10-16
DE60101979D1 (de) 2004-03-18
NO20013223L (no) 2001-12-31
AU782838B2 (en) 2005-09-01
NZ512486A (en) 2001-12-21
KR20020002242A (ko) 2002-01-09
US20020022738A1 (en) 2002-02-21
BR0102604A (pt) 2002-02-13
CA2351273A1 (en) 2001-12-29
TR200400585T4 (tr) 2004-04-21
CN1263736C (zh) 2006-07-12
BR0102604B1 (pt) 2012-06-26
CN1341591A (zh) 2002-03-27
DE60101979T2 (de) 2005-01-05
AU5409201A (en) 2002-03-28
CA2351273C (en) 2010-09-07
MXPA01006698A (es) 2004-07-30
US6552082B2 (en) 2003-04-22
HU0102699D0 (en) 2001-08-28
PT1166773E (pt) 2004-05-31
NO330296B1 (no) 2011-03-21
TWI246925B (en) 2006-01-11
DK1166773T3 (da) 2004-06-07
ATE259218T1 (de) 2004-02-15
EP1166773A1 (en) 2002-01-02
EP1166773B1 (en) 2004-02-11

Similar Documents

Publication Publication Date Title
HUP0303810A3 (en) Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them
HUP0204580A3 (en) Aryl fused azapolycyclic compounds and pharmaceutical compositions containing them
IL127955A0 (en) Pharmaceutical composition containing acid addition salt of basic drug
HUP0400974A3 (en) Peptide-based compounds and pharmaceutical compositions containing them
HUP0200503A2 (en) N-cyanomethyl amides as protease inhibitors and pharmaceutical compositions containing them
HUS1400025I1 (hu) Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
GC0000307A (en) Pyrimidone compounds and pharmaceutical composition containing them
IL201705A0 (en) Site-specific incorporation of redox active amino acids into proteins
HUP0300329A3 (en) Malonamic acids and derivatives and use thereof as thyroid receptor ligands and for preparation of pharmaceutical compositions containing them
HUP0100391A3 (en) Monomeric insulin analogs and their use pharmaceutical composition containing
HUP0302297A3 (en) Substituted thioacetamides and pharmaceutical compositions containing them
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
HUP0203852A3 (en) A physical form of glyburide and composition containing it
HUP0400245A3 (en) Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them
SI1354873T1 (en) Salt of perindopril and pharmaceutical compositions containing it
HUP0301482A3 (en) Quinolinnyl and benzothiazolyl ppar-gamma modulators pharmaceutical compositions containing them and their use
HUP0103257A3 (en) Medicaments containing novel salt form of pantoprazole
HUP0202070A2 (en) Mutual salt of amlodipine and atorvastatin and pharmaceutical composition containing it
HUP0301240A3 (en) Pyridazine compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors and pharmaceutical compositions containing them
HUP0102699A2 (en) Solution of n-[o-(p-pivaloyloxybenzene-sulfonylamino)-benzoyl]-glycine monosodium salt tetrahydrate and pharmaceutical composition containing it
AP2002002575A0 (en) Compounds having hypolupedemic and hypocholestermic activities process for their preparation and pharmaceutical compositions containing them
HUP0400801A3 (en) Pharmaceutical compositions containing bile acid or bile salt fatty acid conjugates and their use
HUP0302478A3 (en) Pharmaceutical solutions of modafinil compounds
HU9700039D0 (en) New oral pharmaceutical formulation containing magnesium salt of omeprazole
IL161103A0 (en) Ibuprofen salt emulsifiers and cream formulations containing same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees